News

Hosted on MSN12m
Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes
Novo Nordisk aims to cement itself as the leading weight loss company globally after Eli Lilly announced its therapy Zepbound (tirzepatide) resulted in more weight loss than Wegovy in a Phase III ...
Stocktwits on MSN58m
Scholar Rock Stock Soars After Investigational Drug Helps Preserve Lean Mass: Retail Flags Lack Of Incremental Weight Loss
Shares of Scholar Rock (SRRK) soared 16% on Wednesday after the company announced that its investigational drug Apitegromab, ...